Xoma | XOMA - Beneficio Bruto En Ventas

Precio De Mercado
38.35
Cambio Diario
1.61 4.38%
Mensual
44.12%
Anual
89.10%
Q2 Expectativa
35.74




Beneficio Bruto En Ventas Cambio Fecha
AbbVie USD 10.47B 605M 2025-09
Agenus USD 34.2M 4.61M 2025-12
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
aTyr Pharma USD 190K 15.57M 2025-09
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Celldex Therapeutics USD 121K 609K 2025-12
Curis USD 1.14M 8.86M 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Incyte USD 1.39B 118.68M 2025-12
MacroGenics USD 31.11M 30.14M 2025-12
Novartis USD 10.25B 570M 2025-12
Novartis USD 10.82B 694M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Prothena USD 21K 2.39M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Xoma 992K 846K 2024-06